share_log

复星医药(600196.SH):桃红四物颗粒获药品注册申请受理

fosun pharma (600196.SH): Taohong Siwu Granule has received the acceptance of pharmaceutical registration application.

Gelonghui Finance ·  Dec 3 16:58

Gelonghui December 3 | fosun pharma (600196.SH) announced that its holding subsidiary Hebei Wanbang Fulin Pharmaceutical Co., Ltd. recently had the pharmaceutical registration application for Taohong Siwu Granules accepted by the National Medical Products Administration. This new drug is a Class 3 traditional chinese medicine, mainly used for nourishing blood, promoting blood circulation, and removing blood stasis, intended for the syndrome of blood deficiency and blood stasis, with symptoms such as irregular menstruation, blood clots, sticky purple complexion, abdominal pain, and bloating. The prescription of this new drug is based on the Taohong Siwu Decoction from the Qing Dynasty's Chai Dehua's "Gynecology Ice Mirror", and has been included in the first batch of the "Catalog of Ancient Classic Prescriptions" by the State Administration of traditional chinese medicine.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment